Peyronie's disease: comparative results of conservative treatment

Abstract

Long-term clinical experience with conservative treatment of Peyronie's disease has demonstrated that clinical efficacy of this therapy comprises maily anesthesia while erectile problems are not solved. Introduction of the drugs into the fibrous plaque is not adequate and hard to perform. Some drugs affect only some components of pathogenesis. For stabilization of the process it is recommended to use transdermal electrophoresis or phonophoresis. The search for new effective drugs and methods continues.

References

  1. Hauck E. W., Diemer T., Weidner W. Peyronie's disease. Conservative and surgical therapy. Urologe A. 2006; 45 (2): W243- W257.
  2. Hellstrom W. J. Medical management of Peyronie's disease. J. Androl. 2009; 30 (4): 397-405.
  3. Mynderse L., Monga M. Oral therapy for Peyronie's disease. Int. J. Impot. Res. 2002; 14: 340-345.
  4. Королева C. B., Ковалев В. А., Саркисян А. Д. и др. Консервативное лечение болезни Пейрони. Урология 2008; 4: 66- 68.
  5. Hellstrom W. J., Cockerham Y. R. Intralesional injection therapy for Peyronie's disease. J. Sex. Med. 2009; 6 (7): 1811-1814.
  6. Мазо Е. Б., Муфагед М. Л., Иванченко Л. П. и др. Консервативное лечение болезни Пейрони в свете новых патогенетических данных. Урология 2006; 2: 32-35.
  7. Levine L. A., Merrick P. F., Lee R. C. Intralesional verapamil injection for the treatment of Peyronie's disease. J. Urol. (Baltimore). 1994; 151: 1522-1524.
  8. Wegner H. E., Andresen R., Knipsel H. H., Miller K. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur. Urol. 1997; 32: 190-193.
  9. Bennett N. E., Guhring P., Mulhall J. P. Intralesional verapamil prevents the progression of Peyronie's disease. Urology 2007; 69 (6): 1181-1184.
  10. Brake M., Loertzer H., Horsch R., Keller H. Treatment of Peyronie's disease with local interferon-alpha-2b. Br. J. Urol. 2001; 87: 654-657.
  11. Nicolai M., Cipollone G., Iantorno R. et al. Intralesional verapamil injection versus placebo in Peyronie's disease. J. Urol. (Baltimore). 1998; 159: 117.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies